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Components of the metabolic syndrome among 
a sample of overweight and obese Costa Rican 
schoolchildren
Abstract 
Background. The term “pediatric metabolic syndrome” 
includes a cluster of cardiovascular risk factors such as 
insulin resistance, dyslipidemia (including increased 
triglycerides and decreased HDL cholesterol), hyper-
tension, and obesity in children. No studies have been 
performed on this syndrome in a pediatric population 
in Costa Rica. 
Objective. To establish the prevalence of metabolic 
syndrome and its components in 8- to 10-year old pre-
puberal overweight and obese schoolchildren.
Methods. This cross-sectional survey was conducted 
in 214 overweight and obese boys and girls, aged 8 to 10 
years, who were selected from six urban schools from 
San José, Costa Rica. Anthropometric measurements and 
determinations of blood glucose, insulin, triglycerides, 
total cholesterol, HDL cholesterol, and high-sensitivity 
C-reactive protein (hs-CRP) were performed. The home-
ostasis model assessment of insulin resistance (HOMA-
IR) index and the Castelli index were calculated to assess 
insulin resistance and cardiovascular risk, respectively. 
Social and lifestyle variables were obtained through 
validated questionnaires. 
Results. A total of 110 boys and 104 girls participated 
in this study; 37.9% of them were overweight and 62.1% 
were obese. Compared with boys, girls were more seden-
tary and had higher insulin levels (16.05 ± 10.45 μIU/
mL vs. 12.72 ± 7.63 μIU/mL, p = .008), body fat (36.5% 
vs. 30.9%, p < .001), and HOMA-IR indexes (3.5 ± 
2.4 vs. 2.8 ± 1.7, p = .014) but lower HDL cholesterol 
(0.99 ± 0.23 mmol/L vs. 1.08 ± 0.27 mmol/L, p = .009). 
Obese children had significantly higher mean serum 
concentrations of insulin, hs-CRP, and triglycerides and 
higher insulin resistance (estimated by HOMA-IR) than 
overweight children, but lower mean serum levels of 
HDL cholesterol. The prevalence of metabolic syndrome 
in the study population was 5.6%. Other risk factors for 
developing cardiovascular disease and type 2 diabetes 
had high prevalence rates among the children: seden-
tarism (40.6%), family history of type 2 diabetes (73.3%), 
high LDL cholesterol levels (≥ 2.84 mmol/L) (57.0%), 
hyperinsulinemia (> 10.5 μIU/mL) (59.8%), insulin 
resistance (estimated by HOMA-IR ≥ 2.4) (55.1%), and 
total cholesterol (> 4.39 mmol/L) (60.7%). Children with 
metabolic syndrome had significantly higher body mass 
indexes, glucose levels, and triglyceride levels and lower 
HDL cholesterol levels than children without metabolic 
syndrome. Insulin had a very strong positive correlation 
with HOMA-IR values (r = 0.982), and hs-CRP had 
a mild positive correlation with body mass index (r = 
0.296) and body fat (r = 0.320).
Conclusions. This study reported a prevalence of 
5.6% of metabolic syndrome among a sample of Costa 
Rican overweight and obese prepuberal children. Lifestyle 
interventions focusing on weight reduction and increas-
ing physical activities should be promoted by education 
and health authorities in order to avoid the early devel-
opment and onset of type 2 diabetes and atherosclerosis 
in childhood.
Key words: Cardiovascular risk, children, dyslipi-
demia, insulin resistance, metabolic syndrome, over-
weight/obesity, syndrome X 
Introduction
The “metabolic syndrome” is a term that is used to 
cluster a number of cardiovascular risk factors such as 
insulin resistance, dyslipidemia (including increased 
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triglycerides and decreased high-density lipoprotein 
[HDL] cholesterol), hypertension, and obesity [1–4]. 
Originally, this condition was defined in adults, but 
in the last decade the term has also been applied to 
children and adolescents [5, 6]. There is no standard 
pediatric definition of metabolic syndrome that is 
accepted by the scientific community at this time, since 
it has not been well characterized in children in terms 
of diagnostic criteria [7]. Therefore, there is little infor-
mation on the epidemiology of metabolic syndrome in 
the pediatric age group [7]. 
However, it is well known that obesity plays a key 
role in metabolic syndrome, since this condition leads 
to insulin resistance and cardiovascular disease [8, 9]. 
The World Health Organization (WHO) has described 
obesity as the world epidemic of the twentieth century 
in all age groups [10–14], and it is considered the sixth 
most important risk factor contributing to the over-
all burden of disease worldwide [15]. In the United 
States in the past 25 years, the frequency of obesity has 
increased by 3.8 times in children aged 6 to 11 years 
(from 4% to 15.3%) and by 2.6 times in the population 
aged 12 to 19 years (from 6.0% to 15.5%) [13]. In Costa 
Rica, according to the Institute for Research and Educa-
tion on Nutrition and Health (INCIENSA), overweight 
and obesity are highly prevalent among schoolchildren 
(34.5% and 26.2% respectively)[16]. Likewise, in the 
past 2 or 3 years the Children’s National Hospital has 
reported an increasing number of cases of insulin resist-
ance in preadolescent boys and girls [17]. However, no 
studies have been performed yet in Costa Rica to study 
the metabolic syndrome in the pediatric population. 
The purpose of this study was to determine the 
frequency of metabolic syndrome and its components 
among a sample of overweight and obese prepuberal 
boys and girls 8 to 10 years old.
Materials and methods
Study population
A total of 214 Hispanic male and female children aged 
8 to 10 years attending public and private schools in the 
city of San José were recruited for this study in 2003. 
The sample size was determined with a confidence level 
of 95% and a sampling error of 5%. Selected overweight 
and obese prepuberal boys and girls from six urban 
schools were invited to participate in this investigation 
after being given a motivational speech and a written 
circular to be taken home. The schools were selected 
with probability proportional to size from a list of 
urban schools in the study area. The inclusion criteria 
included nationality, age, and a body mass index (BMI) 
equal to or greater than the 85th percentile for age and 
sex according to WHO guidelines. Prepuberal state 
(Tanner stage 1) generally refers to boys and girls 10 
years old and under. The mean age of appearance of 
Tanner stage 2, as described in the literature [18] and 
according to the experience of the Children’s National 
Hospital of Costa Rica, is 12 years in girls and 13.5 
years in boys. A total of 420 children agreed to partici-
pate in the study, but only 214 of them fulfilled all the 
inclusion criteria. 
Ethical procedures
Written informed consent was obtained from the par-
ents of the participants, and oral consent was required 
from each child. All procedures followed were approved 
in accordance with the guidelines of the bioethics com-
mittees of the University of Costa Rica and the Costa 
Rican Institute for Research and Education on Nutri-
tion and Health (INCIENSA). 
Sociodemographic and anthropometric variables
Information about the child’s age, sex, and family his-
tory of type 2 diabetes was collected by a validated 
instrument offered to the parents. Another question-
naire designed for the children and administered 
by four trained interviewers assessed the children’s 
physical activities at school, at home, and during leisure 
time. Scores ranged from 0 to 48, and those children 
who scored 30 or less were considered sedentary. 
Weight was measured without the subjects wearing 
shoes or heavy outer clothing. Height was measured 
with the children not wearing shoes and facing away 
from the stadiometer. Standing height was measured 
to the nearest 0.1 cm and weight to the nearest 0.1 
kg. To assess nutritional status, BMI was calculated 
as the weight in kilograms divided by the square of 
the height in meters. Children with BMI at or above 
the 85th percentile for age and sex were considered 
overweight, and those with BMI at or above the 95th 
percentile for age and sex were considered obese. BMI 
data for US children according to age and sex were 
used as cutoff values for the Costa Rican children, as 
recommended by the WHO Expert Committee [19]. 
A leg-to-leg bioimpedance portable device (model 
TBF-401, Tanita Corporation) was used to determine 
percentage of body fat. The children were asked to wear 
light clothing, empty their bladders, remove all metal-
lic objects (rings, necklaces, earrings, and coins), and 
stand barefoot on the machine. Data on sex and height 
were entered manually into the system via a keyboard. 
Body fat was estimated by using the standard built-in 
prediction equations for children and printed out. 
Biochemical variables
Blood was drawn after a 12- to 14-hour fast by 
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antecubital venipuncture according to Clinical and 
Laboratory Standards Institute (CLSI) procedures [20] 
and collected into plain Vacutainer tubes (Becton-
Dickinson). Serum was obtained by centrifugation at 
6,000 rpm for 5 minutes at 25°C, and removal from 
the red cell pack was performed within 30 minutes 
after venipuncture. The samples were stored at –20°C 
until biochemical tests were performed. Insulin was 
determined by immunoassay methods in a fully auto-
mated IMX System (Abbott Laboratories, Diagnostics 
Division Dainabot) with an intra-assay variation of 
8%. High-sensitivity C-reactive protein (hs-CRP) was 
quantified by an enzyme immunoassay test (Diagnos-
tic Automation, Immunodiagnostics Division). Total 
serum cholesterol, HDL cholesterol, triglycerides, and 
glucose were determined by enzymatic colorimetric 
reactions using an Hitachi automated analyzer, model 
911 (Roche). The intra-assay coefficients of variation 
of the assays were 1.8% for total cholesterol, 3.7% for 
HDL cholesterol, 2.1% for triglycerides, and 1.7% for 
glucose. Low-density lipoprotein (LDL) cholesterol 
was calculated by the equation of Friedewald et al. [21]. 
The Castelli index was determined by dividing the total 
cholesterol level by the HDL cholesterol level and was 
defined as indicating a risk of cardiovascular disease 
when it was over 4.5 [22]. Serum levels of total choles-
terol greater than 4.39 mmol/L and of LDL cholesterol 
greater than or equal to 2.84 mmol/L were considered 
as risk factors according to the National Cholesterol 
Education Program Guidelines [23]. A level of hs-CRP 
above 8.2 mg/L was considered high [22], and fasting 
hyperinsulinemia in prepuberal children was defined as 
a serum insulin level greater than 10.5 μIU/mL [7]. 
Insulin resistance was established by the homeos-
tasis model assessment of insulin resistance (HOMA-
IR): [fasting insulin (mIU/L) × fasting glucose 
(mmol/L)]/22.5. Prepuberal participants were classi-
fied as having insulin resistance when HOMA-IR was 
equal to or greater than 2.4 [7]. Metabolic syndrome 
was diagnosed in accordance with the criteria proposed 
by Tapia-Ceballos [10]: high triglyceride levels (≥ 1.24 
mmol/L), low HDL cholesterol (< 1.03 mmol/L), and 
high fasting glucose (≥ 5.55 mmol/L). 
Data analysis
Statistical analysis was performed with SPSS, version 
10.0 for Windows. Student’s t-test was used for the 
analysis of normally distributed data and the Mann-
Whitney U-test for skewed data. Continuous variables 
are expressed as means ± SD and categorical variables 
as frequencies. A value of p < .05 was considered to 
indicate statistical significance. Nonparametric Spear-
man’s correlation coefficients were calculated for bio-
chemical and anthropometric variables. 
Results
The mean age of the 110 boys and 104 girls who par-
ticipated in the study was 9.14 ± 0.80 years; 37.9% 
were overweight and 62.1% were obese, with no sig-
nificant differences in the percentages of overweight 
and obesity between boys and girls. Table 1 shows the 
sociodemographic, anthropometric, and biochemical 
characteristics of the study population. Overall, boys 
and girls had a similar prevalence of family history of 
type 2 diabetes and similar mean values of glucose, 
hs-CRP, triglycerides, total cholesterol, LDL choles-
terol, and Castelli index. More girls than boys were 
sedentary (50.0% vs. 31.8%, p = .010). Girls also had 
higher insulin levels (16.05 ± 10.45 μIU/mL vs. 12.72 
± 7.63 μIU/mL, p = .008), more body fat (36.5% vs. 
30.9%, p < .001), and higher HOMA-IR indices (3.5 
± 2.4 vs. 2.8 ± 1.7, p = .014) than boys but lower HDL 
cholesterol levels (0.99 ± 0.23 mmol/L vs. 1.08 ± 0.27 
mmol/L, p = .009). Obese children had significantly 
higher mean serum concentrations of insulin, hs-CRP, 
and triglycerides than overweight children. Insulin 
resistance, as estimated by HOMA-IR, was also higher 
in obese than in overweight children. Obese children 
had lower mean serum levels of HDL cholesterol than 
overweight children (data not shown).
The prevalence of metabolic syndrome in the study 
population was 5.6% overall (table 2), 3.8% in over-
weight children, and 6.9% in obese children. The 
prevalence of high triglyceride levels (≥ 1.24 mmol/L) 
was 48.1%, 54.7% had low HDL cholesterol (< 1.03 
mmol/L), and 9.3% had high fasting glucose concen-
trations (≥ 5.55 mmol/L). More girls than boys had 
fasting hyperinsulinemia (> 10.5 μIU/mL) (68.3% 
vs. 51.8%, p = .020). Other risk factors for developing 
cardiovascular disease and type 2 diabetes had overall 
high prevalence rates among the study population: 
sedentarism (40.6%), family history of type 2 diabetes 
(73.3%), high LDL cholesterol levels (≥ 2.84 mmol/L)
(57.0%), hyperinsulinemia (> 10.5 μIU/mL) (59.8%), 
insulin resistance (HOMA-IR ≥ 2.4) (55.1%), and high 
total cholesterol levels (> 4.39 mmol/L) (60.7%). 
In the overall population, 48.1% had one of the risk 
factors for the metabolic syndrome, 7.5% had two risk 
factors, and 5.6% had three risk factors (table 3). 
The sociodemographic, anthropometric, and bio-
chemical characteristics of the children with and with-
out metabolic syndrome are summarized in table 4. 
Children with metabolic syndrome had significantly 
higher BMIs (24.45 ± 4.86 vs. 22.54 ± 3.11, p = .047), 
glucose levels (5.84 ± 0.46 mmol/L vs. 4.89 ± 0.43 
mmol/L, p < .001), and triglyceride concentrations 
(2.97 ± 1.34 mmol/L vs. 1.37 ± 0.81 mmol/L, p < .001) 
and lower HDL cholesterol levels (0.81 ± 0.12 mmol/L 
vs. 1.05 ± 0.25 mmol/L, p = .001) than children without 
metabolic syndrome. Among the children with insulin 
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resistance (HOMA-IR ≥ 2.4), the prevalence of meta-
bolic syndrome increased to 8.5% (data not shown).
Nonparametric Spearman correlations among bio-
chemical and anthropometric values showed very 
strong positive correlations between insulin and 
HOMA-IR (r = 0.982) and between total cholesterol 
and LDL cholesterol (r = 0.909). Body fat correlated 
positively with triglycerides (r = 0.376). HDL cho-
lesterol had a mild negative correlation with body fat 
(r = –0.400), triglycerides (r = –0.542), and Castelli 
index (r = –0.684). hs-CRP showed a mild positive 
correlation with BMI (r = 0.296) and body fat (r = 
0.320) (data not shown).
Discussion
To our knowledge, this is the first study that reports the 
prevalence of metabolic syndrome and its components 
among overweight and obese Costa Rican children. 
Definitions by WHO, the National Cholesterol Educa-
tion Program’s Adult Treatment Panel II (NCEP-ATP 
TABLE 1. Sociodemographic, anthropometric, and biochemical characteristics of the study populationa
Characteristic
Boys
(n = 110)
Girls
(n = 104) p valueb
Total
(n = 214)
Age—yr 9.21 ± 0.78
(8.00–10.00)
9.08 ± 0.82
(8.00–10.00)
.236 9.14 ± 0.80
(8.00–10.00)
Nutritional status—%
Overweight 37.3 38.5 .968 37.9
Obese 62.7 61.5 .968 62.1
School—%
Public 80.0 77.9 .834 79.0
Private 20.0 22.1 .834 21.0
Sedentarism—% 31.8 50.0 .010 40.7
Family history of type 2 
diabetes—%
75.2 72.1 .719 73.7
BMI—kg/m2 22.50 ± 3.28 22.80 ± 3.20 .499 22.65 ± 3.24
Body fat—% 30.9 ± 6.8 36.5 ± 6.4 < .001 33.6 ± 7.2
Glucose—mmol/Lc 4.99 ± 0.43
(3.22–6.22)
4.90 ± 0.54
(3.00–7.16)
.178 4.94 ± 0.49
(3.00–7.16)
Insulin—μIU/mL 12.72 ± 7.63
(1.40–57.00)
16.05 ± 10.45
(2.30–77.00)
.008 14.35 ± 9.25
(1.40–77.00)
hs-CRP—mg/L 3.10 ± 2.69
(0.50–10.00)
3.06 ± 2.31
(0.30–10.10)
.907 3.08 ± 2.51
(0.30–10.10)
Total cholesterol—mmol/Ld 4.72 ± 0.88
(2.72–7.12)
4.63 ± 0.93
(2.46–8.44)
.468 4.68 ± 0.91
(2.46–8.44)
HDL cholesterol—mmol/Ld 1.08 ± 0.27
(0.34–1.84)
0.99 ± 0.23
(0.36–1.68)
.009 1.04 ± 0.25
(0.34–1.84)
LDL cholesterol—mmol/Ld 2.98 ± 0.79
(0.85–4.97)
2.96 ± 0.82
(0.98–6.99)
.856 2.97 ± 0.80
(0.85–6.99)
Triglycerides—mmol/Le 1.44 ± 1.05
(0.04–6.27)
1.48 ± 0.78
(0.46–4.25)
.753 1.46 ± 0.92
(0.04–6.27)
Castelli index 4.7 ± 1.5
(2.4–11.0)
4.8 ± 1.3
(2.5–9.4)
.604 4.7 ± 1.4
(2.4–11.0)
HOMA-IR 2.8 ± 1.7
(0.3–11.7)
3.5 ± 2.4
(0.6–18.6)
.014 3.2 ± 2.1
(0.3–18.6)
BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance; HDL, high-density lipoprotein; 
hs-CRP, high-sensitivity C-reactive protein; LDL, low-density lipoprotein
a. Plus–minus values are means ± SD. Numbers in parentheses are ranges.
b. Differences are considered significant if p < .05 (Mann-Whitney test)
c. To convert mmol/L glucose to mg/dL, divide by 0.0555.
d. To convert mmol/L cholesterol to mg/dL, multiply by 38.7. 
e. To convert mmol/L triglycerides to mg/dL, multiply by 88.6.
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III), the European Group for the Study of Insulin 
Resistance, the American College of Endocrinology, 
and the International Diabetes Federation are reported 
in the literature for the diagnosis of metabolic syn-
drome in adults. Table 5 shows the various definitions 
proposed since 2003 for pediatric metabolic syndrome 
and the diagnostic criteria used in each case. Whereas 
Cook et al. [24] and de Ferranti et al. [25] modified 
the adult NCEP-ATP III criteria for adolescents, Viner 
et al. [26] adapted the WHO criteria for children and 
used hyperinsulinism and hypercholesterolemia as 
additional components of the metabolic syndrome. In 
this study, we used the most recent definition proposed 
by Tapia-Ceballos [10] in 2007, which includes the new 
cutoff values for fasting glucose recommended by the 
American Diabetes Association in 2005 [27]. 
The reported prevalence data for metabolic syn-
drome in children and adolescents in different countries 
vary markedly. Some studies worked with the general 
population, and others used samples of overweight and 
obese children. In addition, the inconsistent definition 
criteria used for metabolic syndrome and slightly dif-
ferent cutoff values for triglycerides, HDL cholesterol, 
blood pressure, and fasting glucose could explain the 
discrepancies found in the prevalence data reported 
worldwide [6, 28], making comparisons very difficult. 
Hamidi et al. [3] reported a frequency of metabolic 
syndrome of 20.8% in 505 obese Iranian children aged 
7 to 12 years, and Ferreira et al. [29] reported a similar 
prevalence of 17.3% of metabolic syndrome among 52 
obese Brazilian schoolchildren aged 7 to 10 years. Cook 
et al. [24] analyzed a sample of adolescents aged 12 to 
19 years from the Third National Health and Nutrition 
Examination Survey (NHANES III) using the same 
components of Ferreira’s study but with different cutoff 
points for the parameters. They found a prevalence of 
metabolic syndrome of 6.8% and 28.7% among over-
weight and obese adolescents, respectively. Meanwhile, 
Caceres et al. [30] found a prevalence of metabolic syn-
drome of 36% in a group of 61 obese Bolivian children 
and adolescents aged between 5 and 18 years. In our 
study, we found a prevalence of metabolic syndrome of 
TABLE 2. Prevalence of the metabolic syndrome abnormalities according to the criteria proposed by Tapia-
Ceballos [10] and other well-known cardiovascular risk factorsa 
Risk factor
Boys
(n = 110)
Girls
(n = 104) p valueb
Total
(n = 214)
Metabolic syndrome 4 (3.6) 8 (7.7) .314 12 (5.6)
High triglycerides (≥ 1.24 mmol/L)c 48 (43.6) 55 (52.9) .221 103 (48.1)
Low HDL cholesterol (<1.03 mmol/L)d 50 (45.4) 67 (64.4) .008 117 (54.7)
High fasting glucose (≥ 5.55 mmol/L)e 8 (7.3) 12 (11.5) .412 20 (9.3)
Other risk factors
Sedentarism 35 (31.8) 52 (50.0) .010 87 (40.6)
Family history of type 2 diabetes 82 (75.2) 75 (72.1) .809 157 (73.3)
hs-CRP > 8.2 mg/L 9 (8.2) 6 (5.8) .675 15 (7.0)
LDL cholesterol ≥ 2.84 mmol/Ld 63 (57.3) 59 (56.7) .961 122 (57.0)
Castelli index > 4.5 49 (44.5) 54 (51.9) .344 103 (48.1)
Fasting hyperinsulinemia (> 10.5 μIU/mL) 57 (51.8) 71 (68.3) .020 128 (59.8)
HOMA-IR ≥ 2.4 55 (50.0) 63 (60.6) .155 118 (55.1)
Total cholesterol > 4.39 mmol/Ld 70 (63.6) 60 (57.7) .457 130 (60.7)
HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance; hs-CRP, high-sensitivity 
C-reactive protein; LDL, low-density lipoprotein
a. Figures represent number (percent) of children.
b. Differences are considered significant if p < .05 (Student’s t-test).
c. To convert mmol/L triglycerides to mg/dL, multiply by 88.6.
d. To convert mmol/L cholesterol to mg/dL, multiply by 38.7. 
e. To convert mmol/L glucose to mg/dL, divide by 0.0555.
TABLE 3. Number and percentage of children with none, one, 
two, or three of the risk factors for the metabolic syndrome 
according to the criteria proposed by Tapia-Ceballos [10] 
No. of 
risk 
factors
Boys
(n = 110)
Girls
(n = 104) p valuea
Total
(n = 214)
0 52 (47.3) 31 (29.8) .014 83 (38.8)
1b 48 (43.6) 55 (52.9) .221 103 (48.1)
2c 6 (5.5) 10 (9.6) .379 16 (7.5)
3d 4 (3.6) 8 (7.7) .314 12 (5.6)
a. All differences are significant at p < .05 (Student’s t-test test).
b. Only high serum triglycerides (≥ 1.24 mmol/L) (to convert 
mmol/L triglycerides to mg/dL, multiply by 88.6).
c. High serum triglycerides and low serum HDL cholesterol (< 1.03 
mmol/L) (to convert mmol/L cholesterol to mg/dL, multiply by 
38.7). 
d. High serum triglycerides, low serum HDL cholesterol, and high 
fasting glucose (≥ 5.55 mmol/L) (to convert mmol/L glucose to 
mg/dL, divide by 0.0555).
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3.8% and 6.9%, respectively, among 214 overweight and 
obese schoolchildren from 8 to 10 years of age. Inde-
pendently of the definition used to establish pediatric 
metabolic syndrome, it seems that its prevalence in 
overweight and obese children is increasing to worri-
some limits in many countries [31, 32]. 
In our study, insulin resistance (estimated by HOMA-
IR index) and mean serum concentrations of insulin 
were higher and HDL cholesterol levels were lower in 
girls than in boys and in obese than in overweight chil-
dren. These results are consistent with other studies that 
have shown that obesity is associated with type 2 diabe-
tes, dyslipidemia, and long-term vascular complications 
[33, 34]. Likewise, it has been reported that girls have 
higher basal insulin levels than boys and that the levels 
in girls increase with age [35], a condition that makes 
girls more liable than boys to develop insulin resistance 
and type 2 diabetes. In addition, half of the girls in our 
study had a sedentary lifestyle, and the prevalence of 
low levels of HDL cholesterol was higher in girls than 
in boys (50.0% vs. 31.8%, p = .010); these results suggest 
that encouraging increased physical activity should be 
an important intervention among girls.
Many studies have shown that physical activity 
lowers serum cholesterol, serum triglycerides, serum 
glucose, and blood pressure and improves serum HDL 
cholesterol and insulin sensitivity. Physical activity also 
reduces body weight, modifies body composition, and 
improves cardiovascular fitness and skeletal and mental 
health [36–41]. Recent data also suggest that weight 
reduction can decrease serum levels of C-reactive 
protein [2]. 
Nine of the 12 children diagnosed with metabolic 
syndrome in our study (75%) were obese, a result 
showing the important participation of obesity in 
this condition. Furthermore, children with metabolic 
syndrome had higher serum glucose and triglyceride 
levels and lower HDL cholesterol levels than children 
without this condition, findings that are consistent with 
other investigations [42, 43]. Obese children should be 
TABLE 4. Sociodemographic, anthropometric, and biochemical characteristics of Costa Rican schoolchildren 
with and without metabolic syndromea
Characteristic
Metabolic  
syndrome
(n = 12)
No metabolic 
syndrome
(n = 202) p valueb
Total
(n = 214)
Age—yr 9.67 ± 0.49 9.11 ± 0.81 .019 9.14 ± 0.80
No. males/no. females 4/8 106/96 NS 110/104
No. obese/no. overweight 9/3 124/78 NS 133/81
No. in private schools/no. in public schools 1/11 44/158 NS 45/169
Weight—kg 46.06 ± 11.06 43.23 ± 8.12 .252 43.40 ± 8.30
Height—m 1.37 ± 0.09 1.39 ± 0.23 .765 1.39 ± 0.22
BMI—kg/m2 24.45 ± 4.86 22.54 ± 3.11 .047 22.65 ± 3.24
Body fat—% 36.43 ± 7.07 33.46 ± 7.19 .166 33.6 ± 7.2
Sedentarism—no. (%) 5 (41.7) 82 (40.6) .820 87 (40.7)
Family history of type 2 diabetes—no. (%) 8 (66.7) 149 (73.8) .838 157 (73.4)
Glucose—mmol/Lc 5.84 ± 0.46 4.89 ± 0.43 < .001 4.94 ± 0.49
Insulin—μIU/mL 16.18 ± 8.11 14.24 ± 9.32 .482 14.35 ± 9.25
hs-CRP—mg/L 2.57 ± 1.41 3.11± 2.56 .470 3.08 ± 2.51
Total cholesterol—mmol /Ld 5.10 ± 1.23 4.65 ± 0.88 .094 4.68 ± 0.91
HDL cholesterol—mmol/Ld 0.81 ± 0.12 1.05 ± 0.25 .001 1.04 ± 0.25
LDL cholesterol—mmol/Ld 3.04 ± 1.28 3.14 ± 2.49 .891 3.13 ± 2.44
Triglycerides—mmol/Le 2.97 ± 1.34 1.37 ± 0.81 < .001 1.46 ± 0.92
Castelli index 6.35 ± 1.47 5.87 ± 10.51 .875 5.9 ± 10.2
HOMA-IR 4.21 ± 2.09 3.11 ± 2.08 .077 3.20 ± 2.10
BMI, body mass index; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance; hs-CRP, 
high-sensitivity C-reactive protein; LDL, low-density lipoprotein; NS, not significant
a. Plus–minus values are means ± SD.
b. Differences are considered significant if p < .05 (Mann–Whitney test).
c. To convert mmol/L glucose to mg/dL, divide by 0.0555.
d. To convert mmol/L cholesterol to mg/dL, multiply by 38.7. 
e. To convert mmol/L triglycerides to mg/dL, multiply by 88.6.
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considered a high-risk group for the development of 
insulin resistance, hyperinsulinemia, and cardiovas-
cular disease at young ages. Physical activity should be 
encouraged among children and adolescents to prevent 
these chronic diseases [41, 44]. 
The overall high prevalence rates of other risk fac-
tors for the development of cardiovascular disease and 
type 2 diabetes found among the studied population, 
such as sedentarism (40.6%), family history of type 2 
diabetes (73.3%), high serum LDL cholesterol levels 
(57%), hyperinsulinemia (59.8%), and high serum 
total cholesterol concentrations (60.7%), are alarming, 
particularly if we consider that these factors are associ-
ated with cardiovascular disease in adults in the next 25 
years of life [45] and that in Costa Rica coronary artery 
disease has been the main cause of death among the 
adult population since the 1970s [46]. 
Finally, in our study we determined the serum levels 
of hs-CRP as a marker of subclinical inflammation. 
This acute-phase protein has also been associated 
in the literature with insulin resistance, adiposity, 
atherosclerosis, and metabolic syndrome [47, 48]. In 
our study, obese children had significantly higher mean 
serum concentrations of hs-CRP than overweight chil-
dren (3.52 ± 2.70 vs. 2.04 ± 1.54, p< .001). In addition, 
this protein had a mild positive correlation with BMI 
(r = 0.296) and with percentage of body fat (r = 0.320), 
findings that are consistent with other investigations. 
Adipose tissue secretes interleukin-6, the main stimu-
lant of the hepatic synthesis of CRP. Available evidence 
supports the hypothesis that CRP correlates with 
endothelial dysfunction and that physical exercise and 
diet can reduce the inflammatory response by reducing 
body fat and subsequently CRP levels [49]. hs-CRP is 
used today as a valuable marker of inflammation and 
predictor of coronary events [49]. 
Application of the metabolic syndrome concept 
in children and adolescents is controversial; in fact, 
multiple definitions of the metabolic syndrome have 
been proposed for children, adolescents, and adults 
[50]. However, our data clearly demonstrate that the 
metabolic syndrome and its components are present in 
TABLE 5. Pediatric metabolic syndrome definitions found in the literature as of April 2008
Diagnostic Criteria Cook et ala (2003)
de Ferranti et alb 
(2004) Viner et ald (2005)
Tapia-Ceballose 
(2007)
Abnormal fasting 
glucose homeostasis 
Glucose ≥ 6.1 
mmol/L
Glucose 5.6–7.0 
mmol/Lc
Presence of diabetes mellitus 
type 2 or impaired fasting 
glucose (≥ 6.1 mmol/L) 
or impaired glucose 
tolerance (≥ 7.8 mmol/L 
at 2h) or insulin resistance 
estimated by HOMA-IR
Hyperinsulinaemia 
(additional component)
Presence of glucose 
intolerance or 
diabetes mellitus 
type 2
Obesity Waist perimeter 
≥ P90
BMI above the 95th 
percentile for age 
and sex
BMI above the 95th percen-
tile for age and sex
Waist perimeter 
≥ P90
Dyslipidemia:
High levels of 
triglycerides
≥ 1.24 mmol/L ≥ 1.24 mmol/L ≥1.75 mmol/L ≥ 1.24 mmol/L
Low levels of HDL-
cholesterol
< 1.04 mmol/L ≤ 0.98 mmol/L <0.90 mmol/L < 1.04 mmol/L
High total 
cholesterol
— — > 95th percentile (additional 
component)
—
Arterial hypertension ≥ P90 (Diastolic or systolic) 
> 95th percentile 
adjusted for age, 
height and sex
Systolic > 95th percentile 
adjusted for age and sex
≥ P90
HOMA-IR, homeostasis model assessment for insulin resistance; HDL, high density lipoprotein; BMI, body mass index; P90, percentile
a. Modified version of the National Cholesterol Education Program’s Adult Treatment Panel III (NCEP-ATP III) and must fulfill three of the 
criteria established in the table [10].
b. Modified version of the National Cholesterol Education Program’s Adult Treatment Panel III (NCEP-ATP III) and must fulfill three of the 
criteria established in the table [25].
c. In accordance with American Diabetes Association recommendations (2005) [27].
d. Modified version of the World Health Organization (WHO) and must fulfill glucose intolerance or diabetes mellitus type 2 or insulin 
resistance estimated by HOMA-IR and two more criteria [26]. 
e. Modified version of Cook’s et al definition of MS and must fulfill three of the criteria established in the table [10].
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a large proportion of overweight and obese Costa Rican 
children. Alterations in glucose metabolism, lipid pro-
file, and insulin sensitivity appear early in childhood 
when BMI increases, leading to an early onset of type 2 
diabetes, hypertension, and cardiovascular disease [29, 
51]. Grundy stated recently that persons with metabolic 
syndrome have twice the risk of cardiovascular disease 
and five times the risk of type 2 diabetes as those with-
out the syndrome [52]. As stated by the National Cho-
lesterol Education Program’s Adult Treatment Panel III 
(NCEP-ATP III), obesity should be the primary target 
of intervention for metabolic syndrome [2]. Therefore, 
weight reduction, dietary modification, control of BMI, 
and increasing physical activity should become a public 
health priority in overweight and obese children, and 
these intervention actions should be promoted and 
encouraged in the family, school, and community in 
order to prevent the development of chronic diseases 
in a short time. Primary prevention programs are 
required to identify obesogenic environments, and 
children must be taught to develop healthy food habits 
and increase their physical activity [41, 53]. 
Several limitations of these data should be con-
sidered. First, because the study design was cross-
sectional, hs-CRP was measured in only one sample. 
Second, insulin resistance was estimated mathemat-
ically with HOMA-IR because the gold standard 
method of the euglycemic-hyperinsulinemic clamp is 
too expensive and invasive. Third, body-fat measure-
ments were performed with bioimpedance equipment. 
Although this technique is used by many investigators, 
it is not very accurate. Fourth, the sample of boys and 
girls in this study is not representative of the popula-
tion of 8- to 10-year-old overweight and obese urban 
schoolchildren, which limits the inferences that can be 
drawn with respect to the prevalence of metabolic syn-
drome and its components in this population. Finally, 
we did not measure waist circumference (abdominal 
obesity) in the study population, because at the time we 
collected data, and even today, there is a lack of a stand-
ardized technique for measuring waist circumference 
in children, so that caution needs to be taken when 
comparing waist circumference percentile reference 
data between studies. Several cutoff values for waist 
circumference in children have been suggested, such 
as the age- and sex-specific 75th percentile to define 
moderate waist values [54, 55] and the 90th percentile 
[55–57] or the 95th percentile [54, 58] to define high 
waist values or abdominal obesity. However, a possible 
limitation of these cutoff values is the lack of a gold 
standard research method, such as cross-sectional 
computed tomography to compare the waist circumfer-
ence measures in children. In any case, our results do 
not support the need to measure waist circumference 
in addition to BMI to identify those at increased risk 
for metabolic syndrome in childhood. 
In summary, this study reported a prevalence of 
metabolic syndrome of 5.6% in a sample of over-
weight and obese prepuberal Costa Rican children. 
Lifestyle interventions focused on reducing weight 
and increasing physical activity should be promoted 
by education and health authorities in order to avoid 
the early development and onset of type 2 diabetes and 
atherosclerosis.
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